Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial

被引：0
|
作者：
Benjamin Li
Jose Alvir
Michelle Stewart
机构：
[1] Pfizer,
[2] Pfizer,undefined
来源：
Cardiology and Therapy | 2020年 / 9卷
关键词：
Amyloid; Cardiomyopathies; Heart failure; Survival; Tafamidis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：535 / 540
页数：5
相关论文
共 50 条
  • [1] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Li, Benjamin
    Alvir, Jose
    Stewart, Michelle
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 535 - 540
  • [2] Extrapolation of Data from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) Further Highlights the Survival Benefit of Tafamidis in Transthyretin Amyloid Cardiomyopathy
    Li, Benjamin
    Alvir, Jose
    Stewart, Michelle
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S76 - S76
  • [3] Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy
    Rapezzi, C.
    Kristen, A., V
    Gundapaneni, B.
    Sultan, M. B.
    Hanna, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2115 - 2115
  • [4] Tafamidis for Transthyretin Amyloid Cardiomyopathy
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773
  • [5] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
    Hanna, Mazen
    Damy, Thibaud
    Grogan, Martha
    Stewart, Michelle
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105
  • [6] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 315 - 316
  • [7] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
    Maurer, Mathew S.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama
    Elliott, Perry M.
    Merlini, Giampaolo
    Waddington-Cruz, Marcia
    Kristen, Arnt V.
    Grogan, Martha
    Witteles, Ronald
    Damy, Thibaud
    Drachman, Brian M.
    Shah, Sanjiv J.
    Hanna, Mazen
    Judge, Daniel P.
    Barsdorf, Alexandra I.
    Huber, Peter
    Patterson, Terrell A.
    Riley, Steven
    Schumacher, Jennifer
    Stewart, Michelle
    Sultan, Marla B.
    Rapezzi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1007 - 1016
  • [8] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R. Rene
    Mann, C.
    Duca, F.
    Dachs, T-M
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Kastner, J.
    Eslam, R. Badr
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 252 - 253
  • [9] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Duca, F.
    Binder, C.
    Capelle, C.
    Aschauer, S.
    Eslam, R. Badr
    Mascherbauer, J.
    Hengstenberg, C.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
  • [10] Treatment with Tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Dachs, T.
    Duca, F.
    Binder, C.
    Dusik, F.
    Seirer, B.
    Eslam, R. Badr
    Hengstenberg, C.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S306 - S307
12345